Gelteq Limited Ordinary Shares (GELS)
Gelteq Limited Ordinary Shares operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Clayton, VIC, AU. The stock last traded at $0.56, down 1.75% on the session, giving a market capitalisation of $5.1M. On trailing twelve-month figures it carries a trailing P/E of -2.20, a net margin of -2095.3%. Its beta of -0.43 implies it has historically moved less than the broad market.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Gelteq Limited Ordinary Shares is most often compared with the following Healthcare names: